Coexistence of Hermansky-Pudlak syndrome and JAK2
Essential thrombocythemia
Hermansky-Pudlak syndrome
JAK2V617F
oculocutaneous albinism
storage pool deficiency
Journal
Ultrastructural pathology
ISSN: 1521-0758
Titre abrégé: Ultrastruct Pathol
Pays: England
ID NLM: 8002867
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
2
4
2019
medline:
18
12
2019
entrez:
2
4
2019
Statut:
ppublish
Résumé
Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder consisting of oculocutaneous albinism, platelet storage pool deficiency, and lysosomal accumulation of ceroid lipofuscin. The storage pool deficiency of HPS is associated with the lack of dense bodies in the platelets, resulting in impaired response in the secondary phase of aggregation. Patients with HPS have normal coagulation tests; however, their bleeding time is usually prolonged despite normal or increased platelet counts. Essential thrombocythemia (ET) is an uncommon condition, with an incidence of approximately 1.1 per 100,000/year, and it is the most common cause of primary thrombocytosis. JAK2
Identifiants
pubmed: 30932722
doi: 10.1080/01913123.2019.1593269
doi:
Substances chimiques
JAK2 protein, human
EC 2.7.10.2
Janus Kinase 2
EC 2.7.10.2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM